Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03278574
Other study ID # 25041214
Secondary ID
Status Completed
Phase N/A
First received September 6, 2017
Last updated September 10, 2017
Start date September 5, 2011
Est. completion date December 26, 2016

Study information

Verified date September 2017
Source Meshalkin Research Institute of Pathology of Circulation
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study evaluates the results of mitral valve repair with flexible band in comparison with rigid ring in patients undergoing mitral valve repair for degenerative mitral valve disease


Description:

Currently, mitral ring selection is based on a surgeon's preference rather than evidence. Semirigid rings combine flexibility and stability; however, their clinical benefit has not been completely clarified. The present study aimed to compare the outcomes of mitral valve repair with a flexible posterior annuloplasty band versus complete semirigid ring in patients with degenerative mitral valve disease.


Recruitment information / eligibility

Status Completed
Enrollment 171
Est. completion date December 26, 2016
Est. primary completion date September 29, 2014
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- severe primary mitral regurgitation due to degenerative mitral valve disease

Exclusion Criteria:

- previous open cardiac surgery,

- indication for concomitant aortic valve replacement,

- left ventricle impairment (ejection fraction < 40%).

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Mitral valve repair
Mitral valve repair with standard technique: resection of prolapsed leaflet and/or artificial neochordae implantation
Device:
Ring annuloplasty with posterior band
Mitral valve annuloplasty using Cardiamed (Penza, Russia) flexible posterior annuloplasty band
Ring annuloplasty with complete ring
Mitral valve annuloplasty using Cardiamed (Penza, Russia) complete semirigid ring

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Meshalkin Research Institute of Pathology of Circulation

Outcome

Type Measure Description Time frame Safety issue
Primary Freedom from significant mitral regurgitation Significant mitral regurgitation is defined as moderate and severe mitral regurgitation. The severity of MR was evaluated and defined in accordance with the European Association of Echocardiography recommendations for the assessment of valvular regurgitation 12 months
Secondary Survival Continued existence at follow up 12 months, 24 months
Secondary Freedom from reoperations Freedom from redo mitral valve surgery during follow up 12 months, 24 months
Secondary Freedom from severe MR recurrence The severity of MR was evaluated and defined in accordance with the European Association of Echocardiography recommendations for the assessment of valvular regurgitation 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT04960280 - A Study to Evaluate a Computerized Stethoscope Called ©Voqx to Diagnose Heart Disease N/A
Recruiting NCT05021614 - Valveclip® Transcatheter Mitral Valve Repair Study N/A
Not yet recruiting NCT06167213 - ALLIANCE Mitral: Safety and Effectiveness of SAPIEN X4 Transcatheter Heart Valve - Mitral N/A
Withdrawn NCT05040451 - Carillon Mitral Contour System for Treatment of Exercise Induced Functional Mitral Regurgitation
Withdrawn NCT03714412 - Feasibility Study of Patients With Severe MR Treated With the Cardiovalve TMVR System N/A
Recruiting NCT02592889 - (MitraClip in Non-Responders to Cardiac Resynchronization Therapy) Phase 4
Completed NCT02355418 - The Role of Myocardial Fibrosis in Degenerative Mitral Regurgitation
Completed NCT01841554 - Cardioband With Transfemoral Delivery System N/A
Not yet recruiting NCT01431222 - Abrogation of Mitral Regurgitation Using the MitraClip System in High-Risk Patients Unsuitable for Surgery Phase 4
Not yet recruiting NCT03870516 - Left Chamber Function in Mitral Regurgitation and Predicting Outcome After Replacement and Targeting for Early Surgery N/A
Active, not recruiting NCT03230747 - SAPIEN M3 EFS: Early Feasibility Study of the Edwards SAPIEN M3 System for the Treatment of Mitral Regurgitation N/A
Enrolling by invitation NCT04031274 - Transcatheter Treatment for Combined Aortic and Mitral Valve Disease. The Aortic+Mitral TRAnsCatheter (AMTRAC) Valve Registry
Completed NCT05836480 - Immediate Suboptimal Result of Mitral Valve Repair: Late Implications in a Matched Cohort Study
Completed NCT05836532 - Long Term Results of Surgical and Percutaneous Double Orefices Mitral Repair in Patient With p2 Prolapse Causing Degenerative Mitral Regurgitation
Completed NCT05850026 - Mitral Regurgitation in Hypertrophic Obstructive Cardiomyopathy: Fix it in a Simple, Effective and Durable Way!
Recruiting NCT03975998 - Dutch-AMR: Early Mitral Valve Repair Versus Watchful Waiting in Asymptomatic Patients With Severe Mitral Regurgitation
Completed NCT01162083 - Identifying an Ideal Cardiopulmonary Exercise Test Parameter N/A
Suspended NCT00787293 - Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients Phase 2
Recruiting NCT00745680 - Speckle Tracking Imaging and Realtime 3 Dimensional Echocardiograhy to Study LV Function and Remodeling After Acute Myocardial Infarction (AMI) N/A
Terminated NCT00700947 - Using Beta Blockers to Treat Mitral Regurgitation Phase 1